Breaking News, Promotions & Moves

John Lechleiter to Retire as Lilly CEO

David Ricks will assume president and chief executive roles on January 1, 2017

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Company said John Lechleiter, chairman, president and chief executive officer, will retire as president and chief executive December 31, 2016. He will continue on Lilly’s board of directors until May 31, 2017, serving as non-executive chairman, at which time he will leave the board. Lilly’s board unanimously elected David Ricks, currently senior vice president and president, Lilly Bio-Medicines, to assume the role of president and chief executive officer and to join the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters